Global Green Chemicals Public Company Limited (GGC.BK)
Bangkok, BM, TH
Global Green Chemicals Public Company Limited (GGC) is a prominent producer, distributor, and transporter of oleochemical products, operating across Thailand, China, India, Korea, and other international markets. The company's core business is organized into two primary divisions: Methyl Ester and Fatty Alcohols. GGC manufactures methyl ester, which serves as a key component in biodiesel and as a versatile alternative chemical. Its fatty alcohols are integral to a broad spectrum of goods, including plasticizers, solvents, flavorings, fragrances, detergents, foam stabilizers, lubricants, cosmetics, plastic intermediates, shampoos, paints, coatings, textile and leather processing aids, and printing inks. Furthermore, GGC provides refined glycerine, which finds applications in pharmaceuticals, medical products, creams, lotions, oral hygiene items, resins, plastics, and tobacco. This glycerine also functions as an emollient, offering lubrication and moisture for personal care products, and as an emulsifier for diverse industrial uses. The company's product range also encompasses fatty acids, fatty amines, other alcohol esters, and various by-products, alongside engaging in raw material sales. Originally established in 2005 as Thai Oleochemicals Company Limited, GGC is headquartered in Bangkok, Thailand, and operates as a subsidiary of PTT Global Chemical Public Company Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.50% | -2.46% | +1.02% | +34.69% | +13.14% | +17.16% | -10.41% | -68.82% | -61.55% | -64.64% | -64.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-09 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+4.8% ★ Q1'26: +5.9% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-157.7% Q1'26: +147.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+2.8% Q1'26: -3.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-1.1% Q1'26: +0.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%-2.8% Q1'26: +2.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: -0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.01× ★ Q1'26: 0.47× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
19.47B
est: 18.85B (+3.3%)
|
16.22B
est: 16.23B (0.0%)
|
13.05B
est: 13.09B (-0.3%)
|
18.20B
est: 17.48B (+4.1%)
|
20.92B
est: 19.10B (+9.5%)
|
25.08B
est: 24.40B (+2.8%)
|
17.72B
est: 17.38B (+1.9%)
|
19.01B
est: 19.19B (-0.9%)
|
19.91B
est: 19.33B (+3.0%)
|
19.74B
19.74B – 19.74B
+2.1% YoY
|
20.03B
20.03B – 20.03B
+1.5% YoY
|
20.33B
20.33B – 20.33B
+1.5% YoY
|
| EBITDA |
1.09B
est: 888.31M (+22.4%)
|
-1.03B
est: 764.77M (-234.2%)
|
577.66M
est: 616.98M (-6.4%)
|
1.32B
est: 823.88M (+59.9%)
|
1.09B
est: 900.38M (+21.3%)
|
1.70B
est: 1.15B (+47.4%)
|
440.17M
est: 624.71M (-29.5%)
|
354.38M
est: 689.61M (-48.6%)
|
326.60M
est: 694.68M (-53.0%)
|
709.34M
709.34M – 709.34M
+2.1% YoY
|
719.76M
719.76M – 719.76M
+1.5% YoY
|
730.51M
730.51M – 730.51M
+1.5% YoY
|
| EBIT |
523.23M
est: 322.90M (+62.0%)
|
-1.45B
est: 277.99M (-620.6%)
|
297.21M
est: 224.27M (+32.5%)
|
581.57M
est: 299.48M (+94.2%)
|
470.90M
est: 327.28M (+43.9%)
|
1.09B
est: 418.09M (+161.1%)
|
-62.28M
est: 140.09M (-144.5%)
|
-144.30M
est: 154.64M (-193.3%)
|
-209.40M
est: 155.78M (-234.4%)
|
159.07M
159.07M – 159.07M
+2.1% YoY
|
161.40M
161.40M – 161.40M
+1.5% YoY
|
163.81M
163.81M – 163.81M
+1.5% YoY
|
| Net Income |
520.94M
est: 696.32M (-25.2%)
|
-1.16B
est: -1.16B (-0.1%)
|
94.02M
est: 117.38M (-19.9%)
|
560.14M
est: 561.77M (-0.3%)
|
330.22M
est: 566.97M (-41.8%)
|
953.30M
est: 1.05B (-9.2%)
|
-201.52M
est: -463.99M (+56.6%)
|
-264.93M
est: -281.60M (+5.9%)
|
-683.84M
est: -573.44M (-19.3%)
|
348.16M
348.16M – 348.16M
+160.7% YoY
|
471.04M
471.04M – 471.04M
+35.3% YoY
|
634.88M
634.88M – 634.88M
+34.8% YoY
|
| SGA |
726.97M
est: 757.85M (-4.1%)
|
772.00M
est: 652.45M (+18.3%)
|
828.00M
est: 526.37M (+57.3%)
|
809.00M
est: 702.88M (+15.1%)
|
773.81M
est: 768.15M (+0.7%)
|
904.39M
est: 981.27M (-7.8%)
|
669.92M
est: 731.32M (-8.4%)
|
869.97M
est: 807.30M (+7.8%)
|
1.07B
est: 813.23M (+31.6%)
|
830.40M
830.40M – 830.40M
+2.1% YoY
|
842.60M
842.60M – 842.60M
+1.5% YoY
|
855.18M
855.18M – 855.18M
+1.5% YoY
|
| EPS |
0.56
est: 0.68 (-17.6%)
|
-1.13
est: -1.13 (+0.2%)
|
0.09
est: 0.11 (-19.9%)
|
0.55
est: 0.55 (+0.3%)
|
0.32
est: 0.55 (-42.2%)
|
0.93
est: 1.03 (-9.3%)
|
-0.20
est: -0.45 (+55.9%)
|
-0.26
est: -0.28 (+5.5%)
|
-0.67
est: -0.56 (-19.6%)
|
0.34
0.34 – 0.34
+160.7% YoY
|
0.46
0.46 – 0.46
+35.3% YoY
|
0.62
0.62 – 0.62
+34.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kridsada Prasertsuko | MD & Director | 460.0K | male |
| Jiruss Rianchaiwanich | Vice President of Human Resource & Corporate Support | — | male |
| Kunakorn Witthayapaisarn | Head of Internal Audit & VP of Internal Audit | — | female |
| Pakawan Kamonchaivanich | Vice President of Corporate Strategy & Sustainability | — | female |
| Phromphron Isarankura Na Ayutthaya | Vice President of Operations | — | male |
| Sutthisarn Khongaphirak | Vice President of Corporate Legal | — | male |
| Boodsada Seema | VP of Corporate Affairs & Company Secretary and Head of Compliance | — | female |
| Temwit Jatiyanuwat | CFO, VP of Corporate Finance & Accounting and Head of IR | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GGC.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
